Ubisoft is in a bit of a crunch after the launch of Ghost Recon Breakpoint and The Division 2 failed hard last year. It even delayed a handful of major releases, including Watch Dogs Legion, Rainbow Six Quarantine, and Gods and Monsters. At the time, it was said that the games were delayed so that the teams responsible “would have more development time to ensure that their respective innovations are perfectly implemented so as to deliver optimal experiences for players.” Which pretty much means that finances were an issue thanks to the failures mentioned above and things had to be scaled back, but that’s a discussion for another time.
All we knew at the time was that all three new games would be moved to the company’s 2020-21 fiscal year, which starts on April 1st. During a Q3 investors call earlier today, CEO Yves Guillemot confirmed that all three games are on track, and two other games are also on the way. Watch Dogs Legion, Rainbow Six Quarantine, and Gods and Monsters will arrive sometime between October 1, 2020 and December 31, 2020 – probably before Christmas when sales will have some extra momentum. The other two unnamed games are set for the fourth quarter, or in Ubisoft time, between Jan 1, 2021 and March 31, 2021.
We are excited by the prospect of our lineup. The competitive environment will be challenging, but our production is progressing well, and our games will benefit from strong differentiation pillars. We also believe we have a well-balanced release schedule planned. It is not the first time we have had many releases in a given year, with five triple-As in financial year 15.
Guillemot also hinted that this year won’t be limited to just the five aforementioned games, either. Ubisoft will, apparently, release titles with “deep social layers,” like Roller Champions.
Either way, It looks like it will be at least another year before we see Beyond Good and Evil 2, with Guillemot saying,
On BG&E2, we can’t give you more information except the fact that it’s not going be in the five games we will announce.